As increased NGF in the BALF of asthmatic patients induces smooth muscle hyperplasia in the airway [283,284] and anti-NGF antibodies improve airway hyperresponsiveness [285], NGF is also considered a therapeutic target for lung disease [286]. Here, NGF is linked to lung disorder.